• Profile
Close

Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero

Annals of Rheumatic Diseases Mar 02, 2019

Mofors J, et al. - Given the rarity of congenital heart block (CHB) that may develop in fetuses of Ro/SSA autoantibody-positive women, researchers sought to collect information on comorbidity and complications later in life for large groups of patients and their siblings using the Swedish National Patient Register. They retrieved data from patients with CHB (n= 119) and their siblings (n= 128), all born to anti-Ro/SSA-positive mothers, and from matched healthy controls (n= 1,190) and their siblings (n= 1,071). As per these data, patients with CHB are at increased risk for several cardiovascular, infectious and autoimmune diseases, with the latter risk shared by their siblings.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay